← All stocks

Imunon, Inc.

IMNN Net selling
CIK 0000749647 #5285 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$38.15K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$38.15K
6 of 6 sales
Net
−$38.15K
−$38.15K against sales at will

By person

8 insiders · 6 transactions
0.2×

Stacy Lindborg holds only 0.2 times base salary in stock. $166.38K of shares against $568.14K in salary for 2025.

Salary from the company's own proxy. The shares are what Stacy Lindborg last reported holding, valued at $1.56, the price Common Stock was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Eylward Susan
General Counsel and Corp Sec
$38.15K (6)
−$38.15K
2,896
$4.53K
Lindborg Stacy
President and CEO
106,358
$166.38K
+8,328%
Tardugno Michael H
Executive Chairman of Board
100,321
$156.93K
+914.7%
Faller Douglas Vincent
Chief Medical Officer
41,288
$64.59K
Dentzer James E
Director
21,897
$34.25K
+4,306%
Fritz Frederick J.
Director
21,031
$32.90K
+3,370%
Braun Donald P
Director
15,499
$24.25K
+583.4%
Pellizzari Christine A
Director
15,076
$23.58K
+4,374%

No percentages here. This company's share count has moved by a factor of 6.7 over the window, from 2,192,353 to 14,620,732 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Eylward Susan
31 Aug 2026
General Counsel and Corp Sec
Sell
2,525
$1.56
$3.95K
Eylward Susan
17 Aug 2026
General Counsel and Corp Sec
Sell
2,449
$1.63
$3.99K
Eylward Susan
3 Aug 2026
General Counsel and Corp Sec
Sell
2,541
$1.57
$3.98K
Eylward Susan
20 Jul 2026
General Counsel and Corp Sec
Sell
2,150
$1.78
$3.83K
Eylward Susan
6 Jul 2026
General Counsel and Corp Sec
Sell
920
$1.88
$1.73K
Eylward Susan
29 Jun 2026
General Counsel and Corp Sec
Sell
11,800
$1.75
$20.67K

What was left out

Form 4 filings counted 51
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 319,460
History held since 8 Sep 2016